Early Access Programs: Adding Value to EU Commercialization Strategy, Upcoming Webinar Hosted by Xtalks
TORONTO, March 11, 2024 /PRNewswire-PRWeb/ -- Early access programs (EAPs) act as a bridge to successful commercialization. This webinar will focus on the ways EAPs engage stakeholders and foster advocacy among patient organizations, physicians and key opinion leaders. The session will help gain insights into the best time in clinical development to prepare for launch and the importance of adopting transitional thinking from clinical development to commercial launch.
- In this free webinar, gain practical insights on early access programs (EAPs) in European commercialization.
- The featured speaker will discuss building a strong strategy that includes early stakeholder engagement and transitional thinking
TORONTO, March 11, 2024 /PRNewswire-PRWeb/ -- Early access programs (EAPs) act as a bridge to successful commercialization. - Register now to gain insights into how EAPs act as a bridge to successful commercialization in the EU market.
- Join Heather Masters, VP Global Pricing & Market Access, WEP Clinical , for the live webinar on Thursday, March 28, 2024, at 11am EDT (4pm CET/EU-Central).